Regulatory status as of July 26, 2026: The Pharmacy Compounding Advisory Committee issued favorable recommendations for BPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semax, and an unfavorable recommendation for emideltide/DSIP
Safety advice Do not use during pregnancy or breastfeeding unless your clinician specifically advises it
Tendon gap closure, measured macroscopically in rupture models, is complete or near complete in BPC-157 groups at time points when untreated tendons retain visible defects
Mechanisms of Action Peer-reviewed research, such as Multifunctionality and Medical Potential of BPC-157 in MDPI Pharmaceuticals , outlines its complex, multi-system effects: Angiogenesis: Upregulates VEGF and other growth factors for improved circulation
References Barisic I, Balenovic D, Klicek R, Radic B, Nikitovic B, Drmic D, Udovicic M, Strinic D, Bardak D, Berkopic L, Djuzel V (2013) Mortal hyperkalemia disturbances in rats are NO-system related